R01 DA035949/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2015	6
2016	5
2017	4
2018	9
2019	4
2020	3
2021	1
2022	3
2023	5
2024	2

1

Sideris A, Lauzadis J, Kaczocha M. Sideris A, et al. Anesth Analg. 2024 Jan 1;138(1):42-53. doi: 10.1213/ANE.0000000000006472. Epub 2023 Dec 15. Anesth Analg. 2024. PMID: 38100799 Review.

2

Fatty acid binding protein 5 inhibition attenuates pronociceptive cytokine/chemokine expression and suppresses osteoarthritis pain: A comparative human and rat study.

Gordon C, Trainor J, Shah RJ, Studholme K, Gelman A, Doswell F, Sadar F, Giovannetti A, Gershenson J, Khan A, Nicholson J, Huang Z, Spurgat M, Tang SJ, Wang H, Ojima I, Carlson D, Komatsu DE, Kaczocha M. Gordon C, et al. Osteoarthritis Cartilage. 2024 Mar;32(3):266-280. doi: 10.1016/j.joca.2023.11.010. Epub 2023 Nov 28. Osteoarthritis Cartilage. 2024. PMID: 38035977

3

Proteomic analysis of signaling pathways modulated by FABP5 in macrophages.

Doswell F, Haley JD, Kaczocha M. Doswell F, et al. Res Sq [Preprint]. 2023 Sep 12:rs.3.rs-3332029. doi: 10.21203/rs.3.rs-3332029/v1. Res Sq. 2023. PMID: 37790380 Free PMC article. Preprint.

4

Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain.

Glaser ST, Jayanetti K, Oubraim S, Hillowe A, Frank E, Jong J, Wang L, Wang H, Ojima I, Haj-Dahmane S, Kaczocha M. Glaser ST, et al. Sci Rep. 2023 Sep 14;13(1):15234. doi: 10.1038/s41598-023-42504-4. Sci Rep. 2023. PMID: 37709856 Free PMC article.

5

Truxillic acid monoamides as fatty acid binding protein 5 inhibitors.

Zhu C, Schutz L, Jayanetti K, Takemura K, Doswell F, Wang L, Ojima I, Kaczocha M. Zhu C, et al. Bioorg Med Chem. 2023 Oct 30;94:117464. doi: 10.1016/j.bmc.2023.117464. Epub 2023 Sep 4. Bioorg Med Chem. 2023. PMID: 37708641

6

SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents.

Wang H, Taouil A, Awwa M, Clement T, Zhu C, Kim J, Rendina D, Jayanetti K, Maharaj A, Wang L, Bogdan D, Pepe A, Kaczocha M, Ojima I. Wang H, et al. Bioorg Chem. 2022 Dec;129:106184. doi: 10.1016/j.bioorg.2022.106184. Epub 2022 Sep 30. Bioorg Chem. 2022. PMID: 36244323

7

FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain.

Bogdan DM, Studholme K, DiBua A, Gordon C, Kanjiya MP, Yu M, Puopolo M, Kaczocha M. Bogdan DM, et al. Sci Rep. 2022 Jun 2;12(1):9241. doi: 10.1038/s41598-022-13284-0. Sci Rep. 2022. PMID: 35655086 Free PMC article. Clinical Trial.

8

Mechanisms of endocannabinoid transport in the brain.

Kaczocha M, Haj-Dahmane S. Kaczocha M, et al. Br J Pharmacol. 2022 Sep;179(17):4300-4310. doi: 10.1111/bph.15469. Epub 2021 May 27. Br J Pharmacol. 2022. PMID: 33786823 Free PMC article. Review.

9

Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.

Miller S, Daily L, Dharla V, Gertsch J, Malamas MS, Ojima I, Kaczocha M, Ogasawara D, Straiker A. Miller S, et al. Exp Eye Res. 2020 Dec;201:108266. doi: 10.1016/j.exer.2020.108266. Epub 2020 Sep 23. Exp Eye Res. 2020. PMID: 32979397 Free PMC article.

10

FABP5 as a novel molecular target in prostate cancer.

O'Sullivan SE, Kaczocha M. O'Sullivan SE, et al. Drug Discov Today. 2020 Sep 20:S1359-6446(20)30375-5. doi: 10.1016/j.drudis.2020.09.018. Online ahead of print. Drug Discov Today. 2020. PMID: 32966866 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year